Trials / Completed
CompletedNCT01185717
JC-virus (JCV) Epidemiology in Multiple Sclerosis (MS)
Epidemiology of Anti-JCV Antibody Prevalence in Multiple Sclerosis Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 7,726 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to estimate the prevalence of anti-JCV antibodies in multiple sclerosis (MS) participants.
Detailed description
This is a cross-sectional, multi-center, multi-national, epidemiological study to estimate the prevalence of anti-JCV antibody in MS participants. This study will provide an estimate of the prevalence of anti-JCV antibody in the MS population and will investigate inter-country differences.
Conditions
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2012-05-01
- Completion
- 2012-06-01
- First posted
- 2010-08-20
- Last updated
- 2014-06-02
Source: ClinicalTrials.gov record NCT01185717. Inclusion in this directory is not an endorsement.